Should Venture Firms Bundle Their Biotech Portfolios?
Ron Wooten, president of NovaQuest, an investment and business-development unit of Quintiles Transnational Corp., a contract-research organization, thinks so.
Click here for more information.
Others also viewed
No suggestions are available.
